Latest News and Press Releases

Company announcement – No. 13 / 2019 Zealand Pharma grants new warrants under employee warrant program Copenhagen, April 10, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50...

Press release – No. 07 / 2019 Zealand Pharma to attend Kempen Life Sciences Conference Copenhagen, April 08, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the Kempen Life...

Company announcement – No. 12 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, April 5, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...

Company announcement – No. 11 / 2019 Zealand Pharma announces Emmanuel Dulac as new CEO Emmanuel Dulac will join Zealand Pharma as new Chief Executive Officer on April 22, 2019. Emmanuel comes from...

Company announcement – No. 10 / 2019 Zealand Pharma’s Annual General Meeting in 2019 Copenhagen, April 4, 2019 - Today, Zealand Pharma A/S (Zealand) (CVR-no. 20 04 50 78) held its Annual General...

Press release – No. 06 / 2019 Zealand Pharma to attend Needham Healthcare Conference Copenhagen, April 2, 2019 – Adam Steensberg, Interim Chief Executive Officer, and Marino Garcia, Senior Vice...

Company announcement – No. 09 / 2019 Total number of shares and voting rights in Zealand Pharma at March 31, 2019 Copenhagen, March 29, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a...

Company announcement – No. 8/2019 Zealand Pharma announces completion of the share subscription by Alexion Pharmaceuticals, Inc. and registration of capital increase               Zealand Pharma...

Company announcement – No. 7/2019 Zealand Pharma increases its share capital as a consequence of a new issue of shares               Zealand Pharma A/S' board of directors has exercised an...

Company announcement – No. 06 / 2019         Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases ...